239 related articles for article (PubMed ID: 7734563)
1. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.
Ejaz AA; McShane AP; Gandhi VC; Leehey DJ; Ing TS
Perit Dial Int; 1995; 15(1):61-4. PubMed ID: 7734563
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
3. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
[TBL] [Abstract][Full Text] [Related]
4. A higher magnesium dialysate concentration treats hypomagnesemia.
Eisenman K; Holley JL
Perit Dial Int; 2005; 25(6):604-5. PubMed ID: 16411530
[No Abstract] [Full Text] [Related]
5. Prevalence and factors associated with hypomagnesemia in Southern Chinese continuous ambulatory peritoneal dialysis patients.
Ye H; Zhang X; Guo Q; Huang N; Mao H; Yu X; Yang X
Perit Dial Int; 2013; 33(4):450-4. PubMed ID: 23843592
[No Abstract] [Full Text] [Related]
6. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
7. Measurement of serum ionized magnesium in CAPD patients.
Saha HH; Harmoinen AP; Pasternack AI
Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
[TBL] [Abstract][Full Text] [Related]
8. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of 1.1% amino acid dialysis solution in hypoalbuminemic continuous ambulatory peritoneal dialysis patients.
Taylor GS; Patel V; Spencer S; Fluck RJ; McIntyre CW
Clin Nephrol; 2002 Dec; 58(6):445-50. PubMed ID: 12508967
[TBL] [Abstract][Full Text] [Related]
10. Alkalosis and hypomagnesaemia: unwanted effects of a low-calcium CAPD solution.
Tattersall JE; Dick C; Doyle S; Greenwood RN; Farrington K
Nephrol Dial Transplant; 1995; 10(2):258-62. PubMed ID: 7753461
[TBL] [Abstract][Full Text] [Related]
11. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.
Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R
Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353
[TBL] [Abstract][Full Text] [Related]
12. Short-term increase of glucose concentration in PDS results in extensive removal and high glycation level of vital proteins during continuous ambulatory peritoneal dialysis.
Pešić I; Dihazi GH; Müller GA; Jahn O; Hoffmann M; Eltoweissy M; Koziolek M; Dihazi H
Nephrol Dial Transplant; 2011 Aug; 26(8):2674-83. PubMed ID: 21285129
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium.
Li P; Lv T; Xu L; Yu W; Lu Y; Li Y; Hao J
Ren Fail; 2024 Dec; 46(1):2355354. PubMed ID: 38785302
[TBL] [Abstract][Full Text] [Related]
14. Low- and high-turnover bone disease in continuous ambulatory peritoneal dialysis: effects of low-Ca2+ peritoneal dialysis solution.
Carozzi S; Nasini MG; Santoni O; Pietrucci A
Perit Dial Int; 1993; 13 Suppl 2():S473-5. PubMed ID: 8399644
[TBL] [Abstract][Full Text] [Related]
15. Systemic and intraperitoneal proinflammatory cytokine profiles in patients on continuous ambulatory peritoneal dialysis.
Maksic D; Vasilijic S; Colic M; Stankovic-Popovic V; Bokonjic D
Adv Perit Dial; 2009; 25():50-5. PubMed ID: 19886317
[TBL] [Abstract][Full Text] [Related]
16. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients.
Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF
J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
[TBL] [Abstract][Full Text] [Related]
18. Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients?
Rotellar C; Kinsel V; Goggins M; Tarman G; Stull M; Mazzoni MJ; Mosher WF; Rakowski TA; Winchester JF
Perit Dial Int; 1993; 13 Suppl 2():S471-2. PubMed ID: 8399643
[TBL] [Abstract][Full Text] [Related]
19. The cardiovascular risk factor profiles among end-stage renal failure patients treated with continuous ambulatory peritoneal dialysis and intermittent hemodialysis.
Zamiah SAKS; Draman CR; Seman MR; Safhan AF; Rozalina R; Nik Ruzni NI
Saudi J Kidney Dis Transpl; 2018; 29(1):114-119. PubMed ID: 29456216
[TBL] [Abstract][Full Text] [Related]
20. How long can continuous ambulatory peritoneal dialysis be continued?
Okada K; Takahashi S; Higuchi T; Kinoshita Y; Kikuchi F; Yamauchi T; Yanai M; Kuno T; Nagura Y
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):65-71. PubMed ID: 8336402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
